ROCKET PHARMACEUTICALS, INC.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Performance Stock Units
The following table summarizes the Company’s PSU activity for thenine months ended September 30, 2025:
| Weighted Average | ||
|---|---|---|
| Number of | Grant Date | |
| Shares | Fair Value | |
| Unvested as of December 31, 2024 | 69,661 | $28.71 |
| Granted | - | - |
| Vested | - | - |
| Forfeited | (52,246) | 28.71 |
| Unvested as of September 30, 2025 | 17,415 | $28.71 |
PSU vesting and expense recognition is based on achievement of specific performance goals within certain time periods. PSU awards that are not achieved within specific time periods are forfeited. No performance goals were probable of achievement as of September 30, 2025, and the time periods for two of three performance goals at the beginning of the year expired during the nine months ended September 30, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.